论文部分内容阅读
目的:探讨胸痹方联合西药治疗冠心病稳定型心绞痛的疗效。方法:将100例冠心病稳定型心绞痛患者随机分为实验组和对照组各50例,对照组患者给予肠溶阿司匹林、单硝酸异山梨酯片、阿托伐他汀钙片、酒石酸美托洛尔等常规西药治疗,实验组患者在对照组常规治疗基础上加用胸痹方治疗,观察并记录两组患者治疗前后疗效及血液流变学指标。结果:经1个月治疗,观察组患者心绞痛总有效率为88.0%,优于对照组的72.0%,差异具有统计学意义(P<0.05)。观察组患者心电图总有效率为88.0%,优于对照组的72.0%,差异具有统计学意义(P<0.05)。结论:胸痹方联合西药疗法可抑制血小板聚集、黏附,扩张心血管,降低血压,增强心肌收缩力,同时改善血液黏度,调节血脂浓度,可有效治疗心绞痛,值得临床推广应用。
Objective: To investigate the therapeutic effect of “Chebi Bi 方 combined western medicine” on stable angina pectoris of coronary heart disease. Methods: 100 patients with stable angina pectoris were randomly divided into experimental group and control group, 50 cases in each group. Patients in the control group were given aspirin, isosorbide mononitrate tablets, atorvastatin calcium tablets, metoprolol tartrate tablets, And other conventional western medicine. The patients in the experimental group were given the treatment of chest-embolism on the basis of the routine treatment of the control group. The curative effect and hemorheological indexes of the two groups were observed and recorded before and after treatment. Results: After 1 month treatment, the total effective rate of angina pectoris in observation group was 88.0%, which was better than that in control group (72.0%), the difference was statistically significant (P <0.05). The total effective rate of ECG in observation group was 88.0%, which was better than that in control group (72.0%), the difference was statistically significant (P <0.05). Conclusion: Chebibi combined with Western medicine can inhibit platelet aggregation, adhesion, dilation of cardiovascular, lower blood pressure and increase myocardial contractility, while improving blood viscosity, blood lipid concentration, effective treatment of angina pectoris, worthy of clinical application.